Ozempic Has Arrived in India — But Information Hasn't
Semaglutide, sold under the brand name Ozempic (for diabetes) and Wegovy (for weight loss), has become a global phenomenon. India's anti-obesity drug market surged 115% in 2025, yet most Indians still have basic questions: Is it available here? What does it cost? Is it safe? Let's cut through the noise.
Availability in India (2025 Update)
Both branded and generic semaglutide are now available in India. Novo Nordisk's Ozempic is sold through licensed pharmacies, and several Indian pharmaceutical companies now manufacture biosimilar versions at lower price points. Tirzepatide (Mounjaro) has also launched and achieved rapid adoption.
⚠️ Critical Warning
Never buy GLP-1 medications from unverified online sources. Counterfeit and improperly stored semaglutide is a real and growing problem. Always get a prescription from a licensed doctor.
🆕 2026 Update: Semaglutide Just Got Much Cheaper
Semaglutide's Indian patent expired on 20 March 2026, and 40+ generic versions have launched — pushing prices down to roughly ₹1,300–₹4,200/month and prompting branded Wegovy cuts of up to 48%. For a full breakdown, read our guide to generic semaglutide in India and Mounjaro cost in India 2026.
How MetaFit Makes GLP-1 Accessible
MetaFit's doctors prescribe FDA-approved, CDSCO-verified GLP-1 medications through licensed pharmacy partners. We handle the prescription, the sourcing, the dosing — and we do it at the most competitive prices available. You focus on getting healthier. We handle the logistics. Not sure if you qualify? Check our GLP-1 eligibility guide.
Ready to Start Your Weight Loss Journey?
Get a personalized medical assessment from MetaFit's expert doctors — tailored for the Indian lifestyle.
Book a Free ConsultationOr download the app to get started
